Skip to main content

Articles

Page 1 of 14

  1. In Germany, oral emergency contraception (EC) with the active ingredients levonorgestrel (LNG) and ulipristal acetate (UPA) is available as over-the-counter (OTC) medicine only from community pharmacies (CPs)....

    Authors: Gwenda Lungfiel, Franca Mandlmeier, Christian Kunow and Bernhard Langer
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:68
    Content type: Research Published on:

  2. Early access programs (EAPs) generally refer to patient access to medicines/indications before marketing authorization, possibly extended to price and reimbursement approval. These programs include compassiona...

    Authors: Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, Francesco Costa, Francesco Malandrini and Claudio Jommi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:67
    Content type: Research Published on:

  5. Pharmacists in sales and marketing roles need specific skills for managerial positions, and a framework for evaluating and developing these competencies is necessary. Currently, no such framework is known to e...

    Authors: Hala Sacre, Randa Aoun, Chadia Haddad, Carla Abou Selwan, Rony M. Zeenny, Marwan Akel, Aline Hajj, Carole Hassoun, Joya Namnoum, Katia Iskandar and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:64
    Content type: Research Published on:

  6. Animal diseases are a danger to livestock, businesses, and public health. This is why the public and private sectors in Africa have invested immensely in the manufacture and distribution of veterinary drugs. H...

    Authors: Stevens Kisaka and Frank K. Tumwebaze
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:63
    Content type: Research Published on:

  7. The vast majority of acute diarrheal diseases are self-limiting and do not require treatment on a regular basis. Empirical antibiotics should only be used to treat dysenteric and invasive bacterial diarrhea. A...

    Authors: Beyene Dereje, Shegaye Yibabie, Zenebe Keno and Alemayehu Megersa
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:62
    Content type: Research Published on:

  8. Universal health coverage has gained significant momentum internationally as the policy solution to address healthcare system deficiencies and promote equitable distribution of quality healthcare. The South Af...

    Authors: Vivian Naidoo, Fatima Suleman and Varsha Bangalee
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:61
    Content type: Research Published on:

  9. Insurances in high-income countries (HIC) often contract with private community pharmacies to dispense medicines to outpatients. In contrast, dispensing of medicines in low- and middle-income countries (LMICs)...

    Authors: Warren A. Kaplan, Carlotta M. Cellini, Kwesi Eghan, Kevin Pilz, Denise Harrison and Veronika J. Wirtz
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:60
    Content type: Review Published on:

  10. Antimicrobial resistance (AMR) is a looming pandemic, demanding prompt actions to avert catastrophic consequences. Effluents from pharmaceutical industries containing antimicrobial residues could serve as one ...

    Authors: Anita Kotwani, Ajita Kapur, Mihir Chauhan and Sumanth Gandra
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:59
    Content type: Research Published on:

  11. Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients’ views and experiences of DOACs use and factor...

    Authors: Abdulrhman Al Rowily, Mohamed A. Baraka, Mohammed H. Abutaleb, Aliah M. Alhayyan, Nouf Aloudah, Zahraa Jalal and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:58
    Content type: Research Published on:

  12. A pillar of the United States’ Ending the HIV Epidemic (EHE) initiative is to rapidly provide antiretroviral therapy (ART) in order to achieve HIV viral suppression. However, insurance benefit design can imped...

    Authors: Rohan Khazanchi, Samuel Powers, Amy Killelea, Andrew Strumpf, Tim Horn, Auntré Hamp and Kathleen A. McManus
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:57
    Content type: Research Published on:

  13. A limited number of educational interventions among health care providers and students have been made in Jordan concerning the pharmacovigilance. Therefore, the main aim of this study was to evaluate how an ed...

    Authors: Faris El-Dahiyat, Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Ala’a Momani and Aya Allan
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:56
    Content type: Research Published on:

  14. Administration of potent vaccine in a manner of well-maintained cold chain system is one of the public health focus areas in developing regions of the world. Health professionals’ adherence towards good vaccin...

    Authors: Abebaw Wasie Kasahun, Amare Zewdie, Solomon Shitu and Girma Alemayehu
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:55
    Content type: Review Published on:

  15. COVID-19 booster dose vaccination acceptance and actual vaccination behavior is not known among Egyptian individuals with autoimmune and rheumatic diseases (ARDs). The aim of this study was to investigate the ...

    Authors: Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, Mohammed Kamal Nassar and Marwa Saleh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:54
    Content type: Research Published on:

  16. Few antibiotics have entered the market in recent years despite the need for new treatment options. Some of the challenges of bringing new antibiotics to market are linked to the marketing authorization and he...

    Authors: Cecilia Kållberg, Liv Mathiesen, Unni Gopinathan and Hege Salvesen Blix
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:53
    Content type: Research Published on:

  17. Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot...

    Authors: Madara Paidere, Jūlija Pavlovska, Ieva Rutkovska, Dace Ķikute and Ieva Salmane-Kuļikovska
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:52
    Content type: Research Published on:

  18. The local manufacture of pharmaceuticals is an opportunity to develop a broader manufacturing and knowledge-based economy and reduce over dependence on imports. To promote local production, the Ugandan governm...

    Authors: Kalidi Rajab, Solomon Onen, Diana Kesi Nakitto, Allan Serwanga, Joseph Mutasaaga, Leonard Manirakiza, Denis Mwesigwa, David Nahamya and Helen Byomire Ndagije
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:51
    Content type: Research Published on:

  19. In Indonesia, the world's fourth most populous country, cardiovascular diseases (CVDs) are a leading cause of death and disability. Government efforts to reduce the burden of CVD include a community-based prev...

    Authors: Aksari Dewi, Elizabeth Pisani, Bachtiar Rifai Pratita Ihsan, Ayuk Lawuningtyas Hariadini, Anushka Patel, Anna Palagyi, Devarsetty Praveen, Sujarwoto and Diana Lyrawati
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:50
    Content type: Research Published on:

  20. Pharmacists have been included in general practice teams to provide non-dispensing services in the Australian Capital Territory (ACT) since 2016. Interprofessional collaboration and team effectiveness are key ...

    Authors: Thilini Sudeshika, Louise S. Deeks, Mark Naunton, Gregory M. Peterson and Sam Kosari
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:49
    Content type: Research Published on:

  21. Pharmacists are at the core of the healthcare system and are the most accessible healthcare professionals. Their new roles involve leadership skills, among others. Work satisfaction of pharmacists might affect...

    Authors: Lama Zeineddine, Hala Sacre, Chadia Haddad, M. Rony Zeenny, Marwan Akel, Aline Hajj and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:48
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2023 16:65

  22. Self-medication with antibiotics has become an important factor driving antibiotic resistance and it masks the signs and symptoms of the underlying disease and hence complicates the problem, increasing drug re...

    Authors: Yabibal Berie Tadesse, Abebe Tarekegn Kassaw and Eyayaw Ashete Belachew
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:47
    Content type: Research Published on:

  23. Community pharmacists play a vital role in promoting appropriate use of antibiotics in the community. This study evaluated the practices and perceptions of community pharmacists towards antibiotic use, antibio...

    Authors: Hiba A. Al-Shami, Usman Abubakar, Maryam S. E. Hussein, Hanin F. A. Hussin and Sondos A. Al-Shami
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:46
    Content type: Research Published on:

  24. The COVID-19 pandemic, a serious global health threat, has excruciating social and economic implications given its transmissibility, lack of therapy, and severity. In such a situation, pharmacists as frontline...

    Authors: Sitaram Khadka, Mohammad Saleem, Muhammad Usman, Furqan K. Hashmi, Fatima Tariq, Warda Zaheer, Sabahat Imon, Aqsa Inam, Ravi Prasad Gupta and Pallav Aryal
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:45
    Content type: Research Published on:

  25. Current research to assess the impact that medicine shortages have on patients is limited to general aspects, such as the prevalence of shortages and product characteristics. The aim of this study is to assess...

    Authors: Doerine J. Postma, Kim Notenboom, Peter A. G. M. De Smet, Hubert G. M. Leufkens and Aukje K. Mantel-Teeuwisse
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:44
    Content type: Research Published on:

  26. Pharmacy and pharmaceutical sciences embrace a series of different disciplines. Pharmacy practice has been defined as “the scientific discipline that studies the different aspects of the practice of pharmacy a...

    Authors: Fernando Fernandez-Llimos, Shane Desselle, Derek Stewart, Victoria Garcia-Cardenas, Zaheer-Ud-Din Babar, Christine Bond, Ana Dago, Ramune Jacobsen, Lotte Stig Nørgaard, Carlo Polidori, Manuel Sanchez-Polo, Bernardo Santos-Ramos, Natalia Shcherbakova and Fernanda Tonin
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:43
    Content type: Commentary Published on:

  27. Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether ethnicity and other risk factors play an important role in th...

    Authors: Farideh A. Javid, Fadi Abdul Waheed, Nisa Zainab, Hamza Khan, Ibrahim Amin, Ammar Bham, Mohammed Ghoghawala, Aneem Sheraz and Radi Haloub
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:42
    Content type: Review Published on:

  28. Euthanasia is the last resort for those living with untreatable and terminable diseases which cause pain and suffering. However, the concept of euthanasia resulted in many dilemmas and controversy around life ...

    Authors: Tidenek Mulugeta and Sintayehu Alemu
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:41
    Content type: Research Published on:

  29. Social science research has demonstrated how health practitioners negotiate and contest professional roles and jurisdictions in practice, and in ways that reflect the power dynamics that permeate medicine. Thi...

    Authors: Courtney Addison and Denise Taylor
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:40
    Content type: Research Published on:

  30. The ongoing multi-country outbreak of monkeypox (MPX) that emerges in non-endemic areas is a rare and unprecedented event that has sparked a widespread public health concern. Lebanon has reported four confirme...

    Authors: Dalal Youssef, Edmond Abboud, Malak Kawtharani, Zahraa Zheim, Nisrine Abou Arrage and Janet Youssef
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:39
    Content type: Research Published on:

  31. During the COVID-19 pandemic, the rapid emergence of carbapenem and colistin-resistant Klebsiella pneumoniae has resulted in an alarming situation worldwide. We aimed to describe secondary infections and antimicr...

    Authors: Samaneh Pourajam, Azam Zafarbakhsh, Majid Hosseinzadeh, Mohammad Shirzadi, Mansour Siavash and Hamid Solgi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:38
    Content type: Case study Published on:

  32. Several extended and newly added pharmacy services were evaluated in different countries. This review aims to provide a summary of studies on attitudes, awareness, or perceptions toward various extended and dr...

    Authors: Bayan F. Ababneh, Siew Chin Ong, Fatema Mahmoud, Louai Alsaloumi and Rabia Hussain
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:37
    Content type: Review Published on:

  33. The recent SARS‐CoV‐2 pandemic has resulted in significant morbidity and mortality worldwide. The healthcare systems, including pharmacies, faced unique challenges, such as managing  an overwhelming patient in...

    Authors: Muhammad Hammad, Mohammad Mousa Tashtoush, El Mutasim Ahmed El Faki, Marwa Yousif Hajaj, Saima Saeed Ahmed and Amal Ahmed Darwish
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:36
    Content type: Research Published on:

  34. In many low- and middle-income countries, the 2019 novel coronavirus (COVID-19) has challenged efforts to ensure access to and availability of quality maternal, newborn, and child health (MCH) services and ess...

    Authors: Tsegaye Melaku, Desta Assefa, Fanta Gashe, Mestawet Getachew, Temesgen Kabeta and Zeleke Mekonnen
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:35
    Content type: Research Published on:

  35. Various regulatory authorities are experiencing backlogs of applications which result in delayed access to medicines for patients. The objective of this study is to critically assess the registration process u...

    Authors: Lerato Moeti, Madira Litedu and Jacques Joubert
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:34
    Content type: Research Published on:

  36. Antimicrobial resistance (AMR) is a global public health concern currently mitigated by antimicrobial stewardship (AMS). Pharmacists are strategically placed to lead AMS actions that contribute to responsible ...

    Authors: Ifunanya Ikhile, Gizem Gülpınar, Ayesha Iqbal, Nduta Kamere, Beth Ward, Manjula Halai, Amy Hai Yan Chan, Eric Muringu, Derick Munkombwe, Mashood Lawal, Winnie Nambatya, Yvonne Esseku, Felix Kaminyoghe, Shuwary Barlatt, Eva Muro, Chikondi Savieli…
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:33
    Content type: Research Published on:

  37. Redistribution of essential medicines and health supplies (EMHS) is a mechanism to address supply chain uncertainty by moving excess stock of health commodities from health facilities that are overstocked to h...

    Authors: Immaculate Kyalisiima, Freddy Eric Kitutu, Linda Gibson, Immaculate Akaso, Amos Ndaabe, Herbert Bush Aguma, David Musoke, Richard Odoi Adome and Paul Kutyabami
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:32
    Content type: Research Published on:

  38. Despite the prominent evidence of cold chain monitoring in the health system to reduce wastage and maintain product potency, there are still inefficiencies in the storage and transportation of cold chain produ...

    Authors: Joseph Désiré Nyirimanzi, Joseph Ngenzi, Védaste Kagisha, Thomas Bizimana and Egide Kayitare
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:31
    Content type: Research Published on:

  39. Pharmaceuticals account for a large portion of healthcare spending in healthcare organizations. Their effective inventory management is required to match the cost of stocks with the customer demand and avoid s...

    Authors: Ephrem Mfizi, François Niragire, Thomas Bizimana and Marie Françoise Mukanyangezi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:30
    Content type: Research Published on:

  40. Home isolation has been proposed for coronavirus disease 2019 (COVID-19) patients with mild symptoms to avoid hospital overcrowding. This study aimed to describe the drug-related problems (DRPs) and the pharma...

    Authors: Worapong Sungsana, Chotirat Nakaranurack, Benjabhorn Weeraphon, Watsa Charoenwaiyachet, Supparat Chanprasert, Pattama Torvorapanit, Wichai Santimaleeworagun and Opass Putcharoen
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:29
    Content type: Research Published on:

  41. Critical actions are required for the proper administration of medications to patients with cardiovascular diseases. However, there has been an increase in irrational use of cardiovascular drugs. The purpose o...

    Authors: Ashenafi Kibret Sendekie, Asrat Elias Ergena, Eyayaw Ashete Belachew, Asmamaw Emagn Kasahun, Masho Tigabie Teklie and Adeladlew Kassie Netere
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:28
    Content type: Research Published on:

  42. To reduce pharmacy-related medical expenses, it is necessary to cut drug costs, potentially by increasing generic drug usage. This study analyzes the correlation between generic drug usage and monthly personal...

    Authors: Takaaki Suzuki, Mari Iwata, Mika Maezawa, Misaki Inoue, Riko Satake, Wataru Wakabayashi, Keita Oura, Hideyuki Tanaka, Sakiko Hirofuji, Koumi Miyasaka, Fumiya Goto, Satoshi Nakao, Mayuko Masuta, Kazuhiro Iguchi and Mitsuhiro Nakamura
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:27
    Content type: Research Published on:

  43. MyDispense is a simulation software developed by Monash University that has been utilized by over 200 institutions worldwide to educate pharmacy students. However, little is known about the processes by which ...

    Authors: Harjit K. Singh, Vivienne Mak, Keith Sewell and Daniel T. Malone
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:26
    Content type: Research Published on:

  44. Vaccines require cold chain storage conditions, and good distribution practices throughout the supply chain to maintain their quality and potency. However, in the last mile of the vaccines supply chain, these ...

    Authors: Dennis Kipkoech Sinnei, Peter Ndirangu Karimi, Shital Mahindra Maru, Stephen Karengera and Thomas Bizimana
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:25
    Content type: Research Published on:

  45. Since the deployment of Coronavirus Disease 2019 (COVID-19) vaccines, skepticism about the safety, incidence, and severity of Adverse Events Following Immunization (AEFI) was a concern. The study has two main ...

    Authors: Abeer Zeitoun, Souheil Hallit, Sirine Chehade, Aya Ibrahim, Maya Helali, Carla Allam and Rita Karam
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:24
    Content type: Research Published on:

  46. Inappropriate prescription of antibiotics is a global public health challenge. Widespread use, misuse, or inappropriate prescribing has resulted in unnecessary expenditure on drugs, raised risk of adverse reac...

    Authors: Tamiru Sahilu and Zenebe Kano
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:23
    Content type: Research Published on:

  47. In this article, we focus on the reimbursement process, and as an example, characterize the time to reimbursement of pembrolizumab, a PD-1 immune checkpoint inhibitor for treatment of metastatic NSCLC from public...

    Authors: Sarah Sharman Moser, Frank Tanser, Nava Siegelmann-Danieli, Lior Apter, Gabriel Chodick and Josie Solomon
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:22
    Content type: Review Published on:

  49. Hypertension is a serious threat to public health globally owing to its high prevalence and related complications. It is the main risk factor for cardiovascular disease, kidney disease, eye problems, and death...

    Authors: Dagmawi Teshome Tebelu, Tesfaye Assefa Tadesse, Mihiret Shawel Getahun, Yohannes Mekuria Negussie and Abenet Menene Gurara
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:20
    Content type: Research Published on:

  50. Essential medicines (EMs) are those that satisfy the basic healthcare needs of the population. However, access to EMs remains a global health challenge. The World Health Organization (WHO) and the East African...

    Authors: Ayo-Oley Baldeh, Colin Millard, Allyson M. Pollock and Petra Brhlikova
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:18
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us